Curcumol enhances cisplatin sensitivity of gastric cancer: involvement of microRNA-7 and the nuclear factor-kappa B/snail family transcriptional repressor 1 axis

Cisplatin is a primary chemotherapeutic drug for gastric cancer (GC) patients, but the drug resistance remains the leading cause of treatment failure and high mortality. Curcumol is a bioactive sesquiterpenoid that has reportedly been linked to cisplatin sensitivity in GC. This study focuses on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ying, Xu, Ruitong, Ma, Jinxia, Yan, Zhanpeng, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275945/
https://www.ncbi.nlm.nih.gov/pubmed/35510522
http://dx.doi.org/10.1080/21655979.2022.2070975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275945/
https://www.ncbi.nlm.nih.gov/pubmed/35510522
http://dx.doi.org/10.1080/21655979.2022.2070975

Ejemplares similares